Abstract
Objective
To compare the prevalence of depressive symptoms between prostate cancer (PCa) patients who have received low-dose-rate brachytherapy (LDRB) and those receiving high-dose-rate brachytherapy (HDRB).
Method
Direct comparisons were made between the prevalence of the DSM-IV-TR symptoms of major depressive disorder (MDD) based upon Zung Self-Rating Depression Scale responses and patients’ records on 164 PCa patients from Queensland, Australia.
Results
HDRB patients had significantly greater frequency of self-reported symptoms of crying (or feeling like it) (MDD criterion 1), and restlessness and inability to sit still (MDD criterion 5), and a nonsignificant trend towards more frequent fatigue (MDD criterion 7). There was no significant association between fatigue and having received hormone therapy.
Conclusion
These three MDD symptoms, which include one of the two alternative key required symptoms (criterion 1), suggest that HDRB PCa patients may present with clinically significantly different depression profiles from their peers who receive LDRB. Treatment choices need to be focused upon possible serotonergic dysfunction as well as somatic complaints of depression. The presence of subsyndromal depression in HDRB patients also warrants consideration.
Similar content being viewed by others
References
Kronenwetter C, Weidner G, Pettengill E et al (2005) A qualitative analysis of interview of men with early stage prostate cancer: the prostate cancer lifestyle trial. Nursing 28(2):99–107
Jayadevappa R, Malkowicz S, Chhatre S et al (2011) The burden of depression in prostate cancer. Psycho-oncology 21:1338–1345
Pirl W, Siegel G, Goode M et al (2002) Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psycho-oncology 11:518–523
Grimm P, Billiet I, Bostwick D et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. Br J Urol 109:S22–S29
Jongkamp V, Roeloffzen E, Monninkhof E et al (2012) Brachytherapy for prostate cancer does not influence long-term depression rate. Brachytherapy 11:495–501
Hervouet S, Savard J, Simard S et al (2005) Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. J Pain Symptom Manag 30:474–484
Mahomed N, Bovbjerg D, Montgomery G et al (2012) Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer. Urol Oncol: Semin Orig Investig 30:804–812
Wagner W, Bolling T, Hambruegge C et al (2011) Patients’ satisfaction with different modalities of prostate cancer therapy—a retrospective survey among 634 patients. Anticancer Res 31:3903–3908
Ferrer M, Suarez J, Guedea F et al (2008) Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localised prostate cancer. Int J Radiat Oncol Biol Phys 72:421–432
APA (2013) Diagnostic and statistical manual of mental disorders-V. American Psychiatric Association, Washington, DC
Zung W (1965) A self-rating depression scale. Arch Gen Psychiatry 12:63–70
Zung W (1973) From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry 29:328–337
DeJonge J, Baneke J (1989) The Zung self-rating depression scale: a replication study on reliability, validity and prediction. Psychol Rep 64:833–834
Gabrys J, Peters K (1985) Reliability, discriminant and predictive validity of the Zung self-rating depression scale. Psychol Rep 57:1091–1096
Schaefer A, Brown J, Watson C et al (1985) Comparison of the validities of the Beck, Zung and MMPI depression scales. J Consult Clin Psychol 53:415–418
Sharpley C, Bitsika V, Christie D (2009) Understanding the causes of depression among prostate cancer patients: development of the effects of prostate cancer on lifestyle questionnaire. Psycho-oncology 18:162–168
Sharpley C, Christie D (2007) An analysis of the psychometric structure and frequency of anxiety and depression in Australian men with prostate cancer. Psycho-oncology 16:660–667
Shafer A (2006) Meta-analysis of the factor structures of four depression inventories: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 62:123–146
Agrell B, Dehlin O (1989) Comparison of six depression scales in geriatric stroke patients. Stroke 20:1190–1194
Judd L, Akiskal H, Maser J et al (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694–700
Judd L, Akiskal H, Paulus M (1997) The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 45:5–18
Judd L, Paulus M, Wells K et al (1996) Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry 163:1411–1417
Judd L, Rapaport M, Paulus M et al (1994) Subsyndromal symptomatic depression: a new mood disorder? J Clin Psychiatry 55(4, Suppl):18–28
Lyness J, Heo M, Datto C et al (2006) Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 144(7):496–504
Hassler G, Drevets W, Manji H et al (2004) Discovering endophenotypes for major depression. Neuropsychopharmacology 29:1765–1781
Conn V (2010) Depressive symptom outcomes of physical activity interventions: meta-analysis findings. Ann Behav Med 39:128–138
Conflict of interest
The authors have no conflict of interest to report.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sharpley, C.F., Christie, D.H.R., Bitsika, V. et al. The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patients. Int J Clin Oncol 19, 1080–1084 (2014). https://doi.org/10.1007/s10147-013-0647-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-013-0647-1